Twist Bioscience collaborates with Berry Gene, will jointly develop a new portfolio of NGS products

▴ Twist Bioscience collaborates with Berry Gene, will jointly develop a new portfolio of NGS products
This collaboration can provide a variety of NGS detection solutions

Twist Bioscience, a provider of high quality synthetic DNA through a silicon platform company, today announced a partnership with China's leading Berry Gene, a supplier of high-throughput sequencing (NGS) in China, has reached a strategic cooperation and will add Twist's NGS targeted enrichment and library preparation tools to its products, aiming to promote the high-standard development of precision medical in vitro diagnostics in China.

This product combines Berry Gene's expertise in genomics and high-throughput sequencing (NGS), as well as Twist Bioscience's large-scale manufacturing capabilities, and can provide a variety of NGS detection solutions. The combined product aims to provide researchers with high-quality tools for better application in the screening of tumours and genetic diseases.

"We are very happy to cooperate with Berry Gene, which is one of the most popular and leading companies in the gene sequencing industry in China," said Dr Emily M. Leproust, CEO and co-founder of Twist Bioscience. "Berry has extensive experience in transforming genetic testing technology into clinical applications and has achieved remarkable results. In recent years, Berry Gene has been at the forefront of using NGS to detect diseases and is committed to making more Chinese people enjoy To the health benefits of gene sequencing technology. Twist is honoured to add our NGS solution to Berry Gene’s products."

The NGS products provided by Twist are unique in that they have unparalleled uniformity and have all been quality-verified (QC). The new product will provide Berry Gene with the highest-quality NGS product portfolio today, which will further promote the high-standard development of precision medical in vitro diagnostics in China.

Berry Gene and Twist Bioscience will work closely to develop a more innovative and cutting-edge NGS product portfolio to maintain a leading position in the diagnosis and screening of genetic diseases, and provide Berry Gene with more, better and timely Research and IVD solutions.

Every oligonucleotide of Twist has been verified by NGS to ensure the accuracy of each probe sequence and the presence of all probes in the delivered probe pool, which will further improve the accuracy of our products. We are very I am glad to add Twist NGS series products to our product line. "Dr Zhou Daixing, general manager of Berry Gene said.

Tags : #TwistBioscience #LatestNewsonTwistBioscience22ndFeb #BerryGene #LatestNewsonBerryGene22ndFeb #LatestPharmaNews22ndFeb #LatestPharmaCollaboration22ndFeb #LatestNewsonGeneticDiseases #China

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Children in Cities Exposed to Elevated Lead Levels: Study Reveals Urgent Health ConcernApril 20, 2024
Biocon Ventures into Weight-Loss Drug Market with Semaglutide DevelopmentApril 20, 2024
Innovative AI Assistance Empowers Moscow Doctors to Detect Cervical Spine Issues through MRI ScansApril 20, 2024
Air India Express ties up with AISATS for AeroWash Automated Aircraft Exterior Cleanings April 19, 2024
IndoSup raises strategic funding led by CCI group promoters Naresh Sharma and Satish Sharma; investors include Yatra.com’s Rohan Mittal April 19, 2024
10 compelling reasons why choosing right media platform Is important in healthcareApril 19, 2024
Protecting Public Health: Proposed Guidelines for Pharmaceutical Product DistributionApril 19, 2024
What is Haemophilia: A Genetic Bleeding Disorder that has Affected 1,36,000 IndiansApril 19, 2024
Climate Change and Stroke Risk: Exploring the Impact of Temperature Fluctuations on Your Body April 19, 2024
The Extension and Benefits of ABHA Linking with CGHS Beneficiary ID: What You Need to KnowApril 19, 2024
Mental Health Issues Impact Studies in 3 out 4 Female Students: PeakMind StudyApril 18, 2024
Atal Incubation Centre – Centre for Cellular and Molecular Biology (AIC-CCMB) signs agreement for placement of equipment with Thermo Fisher Scientific to help advance innovation in India April 18, 2024
MiracleMe Introduces Revolutionary Orally Dissolving Plant-Based Nutrition ProductsApril 18, 2024
South Indian Bank signs MOU with Ashok Leyland Limited for Dealer FinancingApril 18, 2024
Serum Institute of India Partners with Oxford University to Develop Meningitis-B VaccineApril 18, 2024
Ethical Concerns Arise: Nestlé Accused of Adding Sugar and Honey to Infant Formula and Breakfast Cereals in Low-Income CountriesApril 18, 2024
Empowering India's Youth: IG Drones & AASSC Launch Drone Skill Program, to Upskill 10M YouthApril 17, 2024
Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment TechnologyApril 17, 2024
Top 5 online learning platform for learnersApril 17, 2024
Broad-Spectrum RNA Vaccine Breakthrough for Enhanced Virus ProtectionApril 17, 2024